2024-10-23 REL PDBe PDBe PDBe 2021-04-19 2021-08-11 2021-08-11 2024-10-23 Wellcome Trust 100209/Z/12/Z) United Kingdom Engineering and Physical Sciences Research Council EP/S025243/1 United Kingdom Nanobody C5 bound to Spike Naismith JH Weckener M Spike, nanobody, high affinity, ANTIVIRAL PROTEIN Huo J Mikolajek H Le Bas A Clark JJ Sharma P Kipar A Dormon J Norman C Weckener M Clare DK Harrison PJ Tree JA Buttigieg KR Salguero FJ Watson R Knott D Carnell O Ngabo D Elmore MJ Fotheringham S Harding A Moynie L Ward PN Dumoux M Prince T Hall Y Hiscox JA Owen A James W Carroll MW Stewart JP Naismith JH Owens RJ A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun UK 12 5469 5469 2021 34552091 doi:10.1038/s41467-021-25480-z 2041-1723 Huo J Mikolajek H Le Bas A Clark J Sharma P Kipar A Dormon J Norman C Weckener M Clare D Harrison P Tree J Buttigieg K Salguero F Watson R Knott D Carnell O Ngabo D Elmore M Fotheringham S Harding A Ward P Moynie L Dumoux M Hall Y Hiscox J Owen A James W Carroll M Stewart J Naismith J Owens R A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 Res Sq US 2021 doi:10.21203/rs.3.rs-548968/v1 2693-5015 7oan FULLOVERLAP nanobody complex nanobody complex 0 1 2
proteins produced incubated and run on grids
Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Severe acute respiratory syndrome coronavirus 2 0.13987790599999997 3 Homo sapiens LEVO MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFD NPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVY SSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRV QPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSF VIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGS NVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPGSASSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGF NFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAG TITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN TLVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRV DFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL QELGKYEQGSGYIPEAPRDGQAYVRKDGEWVLLSTFLSLLNDIFEAQKIEWHEKHHHHHH P0DTC2 immunoglobulin mu heavy chain Vicugna pacos 0.013907522 3 Escherichia coli LEVO MAQVQLVESGGGSVQAGGSLTLSCVASGVTLGRHAIGWFRQAPGKERERVSCIRTFDGITSYVESTKGRFTISSNNAMNT VYLQMNSLKPEDTAVYFCALGVTAACSDNPYFWGQGTQVTVSSHHHHHH 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 36 NAG singleParticle twoDArray 0.1 7.0 100.0 Tris
Standard buffer
 ETHANE
The sample well dispersed
 FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 FEI FALCON III (4k x 4k) 50.0 1
high pass filter
6VXX C3 3.0 FSC 0.143 CUT-OFF 227898 NOT APPLICABLE OTHER emd_12777.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 317.99997 317.99997 317.99997 90.0 90.0 90.0 X Y Z -0.02473875 0.073298365 0.00011917729 0.0021465044 1.06 1.06 1.06 0.0099 AUTHOR Map